Quaker Wealth Management’s Gilead Sciences GILD Stock Holding History

Quaker Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$131K	Buy	1,038 +49	+5%	+$6.46K	0.04%	96
2026 Q1	$138K	Sell	989 -88	-8%	-$12.3K	0.04%	91
2025 Q4	$132K	Buy	1,077 +5	+0.5%	+$608	0.04%	93
2025 Q3	$119K	Buy	1,072 +21	+2%	+$2.39K	0.04%	96
2025 Q2	$117K	Buy	+1,051	New	+$112K	0.04%	96

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Quaker Wealth Management's GILD Position: Q2 2026 in Review

Quaker Wealth Management increased its Gilead Sciences (GILD) stake by 5% in Q2 2026, buying an estimated $6.46K and bringing the position to 1,038 shares worth $131K. The position accounts for 0.04% of the portfolio, ranked #96.

Quaker Wealth Management first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $138K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Quaker Wealth Management held 1,038 shares of Gilead Sciences worth $131K as of Q2 2026.
Quaker Wealth Management bought 49 Gilead Sciences shares in Q2 2026, an estimated $6.46K.
Gilead Sciences made up 0.04% of Quaker Wealth Management's portfolio in Q2 2026, its #96 holding.
Quaker Wealth Management first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
Quaker Wealth Management's Gilead Sciences position peaked at $138K in Q1 2026.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.